CD4⁺ T cells kill Id⁺ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo

Author： Lundin Katrin Screpanti Valentina Omholt Hilde Hofgaard Peter Yagita Hideo Grandien Alf Bogen Bjarne

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.53, Iss.12, 2004-12, pp. : 1135-1145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo

By Perabo F.G.E. Mattes R.H. Wirger A. Steiner G. Kamp S. Schmidt D. Pegelow K. von Ruecker A. Muller S.C.

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 4, 2001-07 ,pp. : 163-169

Elsevier

Access to resources Recommend Favorite

Okadaic acid stimulates expression of Fas receptor and Fas ligand by activation of nuclear factor kappa-B in human oral squamous carcinoma cells

By Fujita M. Goto K. Yoshida K. Okamura H. Morimoto H. Kito S. Fukuda J. Haneji T.

Oral Oncology, Vol. 40, Iss. 2, 2004-02 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

The mechanism of killing of B-lymphoma cells by ¹¹¹In-conjugated antibodies

By Mattes M. Jules

International Journal of Radiation Biology, Vol. 84, Iss. 5, 2008-07 ,pp. : 389-399

Informa Healthcare

Access to resources Recommend Favorite

Ganoderma lucidum polysaccharides counteract inhibition on CD71 and FasL expression by culture supernatant of B16F10 cells upon lymphocyte activation

Experimental and Therapeutic Medicine, Vol. 5, Iss. 4, 2013-01 ,pp. : 1117-1122

Spandidos Publications

Access to resources Recommend Favorite

Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-β pathway

International Journal of Oncology, Vol. 47, Iss. 2, 2015-01 ,pp. : 747-757

Spandidos Publications

Access to resources Recommend Favorite